Ainos, Inc. (AIMD)
NASDAQ: AIMD · Real-Time Price · USD
2.870
-0.010 (-0.35%)
At close: Jul 15, 2025, 4:00 PM
2.860
-0.010 (-0.35%)
After-hours: Jul 15, 2025, 4:00 PM EDT
Ainos Revenue
Ainos had revenue of $106.21K in the quarter ending March 31, 2025, with 412.36% growth. This brings the company's revenue in the last twelve months to $106.21K, up 13.38% year-over-year. In the year 2024, Ainos had annual revenue of $20.73K, down -83.02%.
Revenue (ttm)
$106.21K
Revenue Growth
+13.38%
P/S Ratio
65.22
Revenue / Employee
$2,414
Employees
44
Market Cap
11.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20.73K | -101.38K | -83.02% |
| Dec 31, 2023 | 122.11K | -3.40M | -96.53% |
| Dec 31, 2022 | 3.52M | 2.93M | 491.97% |
| Dec 31, 2021 | 594.56K | 578.00K | 3,489.71% |
| Dec 31, 2020 | 16.56K | 4.83K | 41.19% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
AIMD News
- 5 days ago - Water Tower Research Highlights Growing Momentum for Ainos' Scent-Tech Solutions and Industrial SmellTech Leadership with New High-Impact Partnerships - Accesswire
- 8 days ago - Ainos and Solomon Partner to Bring SmellTech Across Asia's Industrial Landscape - Accesswire
- 15 days ago - Ainos Completes Stock Consolidation, Enters New Phase of Global Expansion and Technology Commercialization - Accesswire
- 18 days ago - Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites - Accesswire
- 19 days ago - Ainos Aligns Capital Structure With 2H 2025 Execution Roadmap; Announces Stock Consolidation - Accesswire
- 21 days ago - Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia - Accesswire
- 4 weeks ago - Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25 - Accesswire
- 4 weeks ago - Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy - Accesswire